Frequency and predictors of ventilator-associated pneumonia recurrence: A meta-analysis

Shock

Volumn 30, Issue 5, 2008, Pages 487-495

  Siempos, Ilias I ^a   Athanassa, Zoe ^a   Falagas, Matthew E ^a,b,c  

^a HENRY DUNANT HOSPITAL   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

Author keywords

Intensive care unit; Multidrug resistant bacteria; Nosocomial pneumonia; Pseudomonas aeruginosa; Relapse; Staphylococcus aureus; Superinfection

Indexed keywords

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BACTEREMIA; DISEASE SEVERITY; HUMAN; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; PREDICTION; PSEUDOMONAS AERUGINOSA; RECURRENCE RISK; RELAPSE; RISK FACTOR; SEPSIS; SEX RATIO; SHOCK; STAPHYLOCOCCUS AUREUS; SUPERINFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; VENTILATORS, MECHANICAL;

EID: 55949086875     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31816f1f7c     Document Type: Article

References (39)

1. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867-903, 2002.
2. Kollef MH: The prevention of ventilator-associated pneumonia. N Engl J Med 340:627-634, 1999.
3. Siempos II, Vardakas KZ, Kopterides P, Falagas ME: Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med 35:2843-2851, 2007.
4. Siempos II, Falagas ME: Oral decontamination with chlorhexidine reduces the incidence of nosocomial pneumonia. Crit Care 11:402, 2007.
5. The American Thoracic Society and the Infectious Diseases Society of America Guideline Committee: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388-416, 2005.
6. Dodek P, Keenan S, Cook D, Heyland D, Jacka M, Hand L, Muscedere J, Foster D, Mehta N, Hall R, et al., Canadian Critical Care Society Canadian Critical Care Trials Group: Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 141:305-313, 2004.
7. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, Healthcare Infection Control Practices Advisory Committee: Guidelines for preventing healthcare-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Morb Mortal Wkly Rep 53:1-36, 2004.
8. Hubmayr RD, Burchardi H, Elliot M, Fessler H, Georgopoulos D, Jubran A, Limper A, Pesenti A, Rubenfeld G, Stewart T, et al.: American Thoracic Society Assembly on Critical Care; European Respiratory Society; European Society of Intensive Care Medicine; Société de Réanimation de Langue Française: Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia - Chicago, Illinois, May 2002. Intensive Care Med 28:1521-1536, 2002.
9. Torres A, Carlet J, the European Task Force on Ventilator Associated Pneumonia: Ventilator associated pneumonia. Eur Respir J 17:1034-1045, 2001.
10. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J: Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 35:146-154, 2007.
11. Combes A, Figliolini C, Trouillet JL, Kassis N, Dombret MC, Wolff M, Gibert C, Chastre J: Factors predicting ventilator-associated pneumonia recurrence. Crit Care Med 31:1102-1107, 2003.
12. Silver DR, Cohen IL, Weinberg PF: Recurrent Pseudomonas aeruginosa pneumonia in an intensive care unit. Chest 101:194-198, 1992.
13. Rello J, Mariscal D, March F, Jubert P, Sanchez F, Valles J, Coll P: Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients. Relapse or reinfection? Am J Respir Crit Care Med 157:912-916, 1998.
14. Stephan S, Mabrouk N, Decailliot F, Declaux C, Legrand P: Ventilator-associated pneumonia leading to acute lung injury after trauma. Anesthesiology 104:235-241, 2006.
15. Luyt CE, Guerin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J: Procalcitonin kinetics as a prognostic marker of ventilator- associated pneumonia. Am J Respir Crit Care Med 171:48-53, 2005.
16. Siempos II, Ioannidou E, Falagas ME: The difference between adequate and appropriate antimicrobial treatment. Clin Infect Dis 46:642-644, 2008.
17. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med149:818-824, 1994.
18. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986.
19. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J: Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia. Intensive Care Med 32:1970-1978, 2006.
20. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Gibert C, Chastre J, for the PNEUMA Trial Group: Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 170:786-792, 2004.
21. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, et al.: PneumA Trial Group: comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588-2598, 2003.
22. Dennesen PJW, Van der Ven AJAM, Kessels AGH, Ramsay G, Bonten MJM: Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 163:1371-1375, 2001.
23. Vidaur L, Gualis B, Rodriguez A, Ramirez R, Sandiumenge A, Sirgo G, Diaz E, Rello J: Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome. Crit Care Med 33:1248-1253, 2005.
24. Bonten MJM, Bergmans DCJJ, Stobberingh EE, Van der Geest S, De Leeuw PW, Van Tiel FH, Gaillard CA: Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med 156:1820-1824, 1997.
25. Rello J, Ausina V, Castella J, Net M, Prats G: Nosocomial respiratory tract infections in multiple trauma patients: influence of level of consciousness with implications for therapy. Chest 102:525-529, 1992.
26. Rello J, Quintana E, Ausina V, Castella J, Liquin M, Net A, Prats G: Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 100:439-444, 1991.
27. Ibrahim EH, Ward S, Sherman G, Schaiff R Fraser VJ, Kollef MH: Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29:1109-1115, 2001.
28. Combes A, Figliolini C, Trouillet JL, Kassis N, Wolff M, Gibert C, Chastre J: Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 121:1618-1623, 2002.
29. Wahl WL, Franklin GA, Brandt MM, Sturm L, Ahrns KS, Hemmila MR, Arbadi S: Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit? J Trauma 54:633-639, 2003.
30. Zahar JR, Clec'h C, Tafflet M, Garrouste-Orgeas M, Jamali S, Mourvillier B, De Lassence A, Descorps-Declere A, Adrie C, Costa de Beauregard MA, et al.: Is methicillin resistance associated with a worse prognosis in staphylococcus aureus ventilator-associated pneumonia? Clin Infect Dis 41:1224-1231, 2005.
31. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748, 1959.
32. Bonten MJ, Kollef MH, Hall JB: Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 38:1141-1149, 2004.
33. Chastre J, Trouillet JL, Vuagnat A, Joly-Guillou ML, Clavier H, Dombret MC, Gibert C: Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 157:1165-1172, 1998.
34. Fagon JY, Chastre J: Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients. Eur Respir J 22:77s-83s, 2003.
35. Chollet-Martin S, Jourdain B, Gibert C, Elbim C, Chaster J, Gougerot-Pocidalo MA: Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 154:594-601, 1996.
36. Sakr Y, Vincent JL, Schuerholz T, Filipescu D, Romain A, Hjelmqvist H, Reinhart K, on behalf of the SOAP investigators: Early- versus late-onset shock in European intensive care units. Shock 28:636-643, 2007.
37. Phua J, Koay ES, Lee KH: Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 29:328-333, 2008.
38. Ueda S, Nishio K, Akai Y, Fukushima H, Ueyama T, Kawai Y, Masui K, Yoshioka A, Okuchi K: Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 26:134-139, 2006.
39. Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP: A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock 26:551-557, 2006.